Differential distribution of [3H]sumatriptan binding sites (5-HT(1B), 5-HT(1D) and 5-HT(1F) receptors) in human brain: Focus on brainstem and spinal cord

Neuropharmacology

Volumn 36, Issue 4-5, 1997, Pages 535-542

  Castro, M E ^a   Pascual, J ^a,b   Romon T ^a   Del Arco, C ^a   Del Olmo, E ^a   Pazos, A ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

5 Carboxamidotryptamine; 5 HT(1B) receptor; 5 HT(1D) receptor; 5 HT(1F) receptor; 3H sumatriptan; Ketansern

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 5 CARBAMOYLTRYPTAMINE; KETANSERIN; MESULERGINE; RADIOLIGAND; RECEPTOR SUBTYPE; SEROTONIN; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 1F RECEPTOR; SEROTONIN RECEPTOR; SUMATRIPTAN; 5-CARBOXAMIDOTRYPTAMINE; DRUG DERIVATIVE; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

ADULT; ANTINOCICEPTION; ARTICLE; AUTOPSY; AUTORADIOGRAPHY; BINDING COMPETITION; BRAIN REGION; BRAIN STEM; CONTROLLED STUDY; DRUG BINDING SITE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY; SOLITARY TRACT NUCLEUS; SPINAL CORD; SUBSTANTIA GELATINOSA; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION; TRIGEMINAL NUCLEUS; AGED; BRAIN LEVEL; DRUG EFFECT; HISTOLOGY; IN VITRO STUDY; MEMBRANE; METABOLISM; MIDDLE AGED; PREFRONTAL CORTEX; RADIOASSAY;

AGED; AUTORADIOGRAPHY; BINDING, COMPETITIVE; BRAIN CHEMISTRY; BRAIN STEM; HUMANS; KETANSERIN; MEMBRANES; MIDDLE AGED; PREFRONTAL CORTEX; RADIOLIGAND ASSAY; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SPINAL CORD; SUMATRIPTAN;

EID: 0030610865     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00061-0     Document Type: Article

References (33)

1. 1 receptor subtype coupled to the inhibition of adenylyl cyclase. Proc. natn Acad. Sci. U.S.A. 90: 408-412.
2. 125I]tyrosinamide labels the 5-HT1Dβ receptor subtype in human cortex. Eur. J. Pharmacol. 242: 195-198.
3. Bennet J. P. and Yamamura H. I. (1985) Neurotransmitter, hormone, or drug receptor methods. In: Neurotransmitter Receptor Binding (Yamamura H. I., Enna S. J. and Kuhard M. J. Eds), pp. 61-90. Raven Press, New York.
4. Boess F. G. and Martin I. L. (1994) Molecular biology of 5-HT receptors. Neuropharmacology 33: 275-317.
5. 1D binding sites in human and guinea-pig brain using different radioligands. Mol. Brain Res. 21: 19-29.
6. 1F receptor messenger RNA in rodent and primate brain. Neuropharmacology 33: 367-386.
7. Goadsby P. J. and Edvinsson L. (1993) The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuro-peptide changes seen in humans and cats. Ann. Neurol. 48-56..
8. 1D-like pharmacological specificity. Biochem. Biophys. Res. Commun. 184: 752-759.
9. 1D receptor subtypes. Trends Pharmacol. Sci. 17: 103-105.
10. 3H]S-HT binding site subtype in bovine brain membranes. J. Neurosci. 7: 894-903.
11. 1C sites. Neurosci. Lett. 85: 357-362.
12. Hoyer D., Clarke D. E., Fozard J. R., Hartig P. R., Martin G. R., Mylecharane E. J., Saxena P. R. and Humphrey P. P. A. (1994) VII International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmac. Rev. 46: 157-203.
13. Humphrey P. P. A. and Feniuk W. (1991) Mode of action of the antimigraine drug sumatriptan. Trends Pharmac. Sci. 12: 444-446.
14. 1E) in human brain: interaction with a GTP-binding protein. J. Neurochem. 53: 465-471.
15. 1D in the rabbit and guinea-pig brain cortex. Naunyn-Schmiedeberg's Arch. Pharmac. 343: 353-364.
16. Lowry O. H., Rosebrough N. J., Farr A. N. and Randall R. J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275.
17. 1 receptor. Naunyn-Schmiedeberg's Arch. Pharmac. 334: 323-326.
18. 1-like subtype. Proc. natn Acad. Sci. U.S.A. 89: 5517-5521.
19. 3H] sumatriptan binding in cat brain stem and spinal cord. Eur. J. Pharmac. 280: 175-178.
20. Moskowitz M. A. (1992) Neurogenic versus vascular mechanisms of sumatriptan and ergot extravasation in dura mater: proposed action in vascular headaches. Trends Pharmac. Sci. 13:307-311.
21. Munson P. J. and Rodbard D. (1980) LIGAND: a versatile computerized approach for the characterization of ligand binding systems. Analyt. Biochem. 107: 220-239.
22. 1D receptors in human brain using a new iodinated radioligand. Mol. Brain Res. 13: 175-179.
23. 1F receptors. Eur. J. Pharmac. 295: 271-274.
24. Pazos A., Hoyer D. and Palacios J. M. (1984) The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. Eur. J. Pharmac. 106: 539-546.
25. Peroutka S. J. (1994) Molecular biology of serotonin (5-HT) receptors. Synapse 18: 214-260.
26. Plosker G. L. and McTavish D. (1994) Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs 47: 622-651.
27. 1F receptors binding sites in the guinea pig brain. Br. J. Pharmac. 114 (Suppl.): 364P.
28. 3H]ultrofilm: application to multiple benzodiazepine receptors. J. Neurosci. Meth. 6: 59-73.
29. 1F receptor binding sites in the guinea pig brain: an autoradiographic study. Naunyn-Schmiedeberg's Arch. Pharmac. 352: 263-275.
30. 1D receptors in the guinea pig brain: pre and postsynaptic localizations in the striatonigral pathway. Brain Res. 528: 197-206.
31. 1Dβ. Proc. natn Acad. Sci. U.S.A. 89: 3630-3634.
32. 1Dα antagonists. Soc. Neurosci. Abstr. 20: 6337.
33. 1D receptors subtypes. Naunyn-Schmiedeberg's Arch. Pharmac. 354: 226-236.